Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient with progressive renal failure due to
multiple myeloma
presented with a mixed acid-base disorder (non-anion gap acidosis and respiratory alkalosis) with persistent severe hyperkalemia. Studies revealed an intact ability to lower urine pH during acid loading, markedly decreased plasma renin and aldosterone concentrations despite volume depletion, and an inappropriately low fractional excretion of potassium. Renal biopsy demonstrated plasma cell infiltration of the renal interstitium and typical proteinaceous intratubular casts. Both proximal and distal renal tubular acidification defects have been described previously in patients with
multiple myeloma
, but this is the first report of
hyporeninemic hypoaldosteronism
, hyperkalemia, and hyperchloremic metabolic acidosis in association with renal involvement in
multiple myeloma
.
...
PMID:Hyporeninemic hypoaldosteronism in a patient with multiple myeloma. 638 30
Hyporeninemic hypoaldosteronism
is an important underlying condition, causing hyperkalemia with hyperchloremic metabolic acidosis, disproportionate to the degree of renal insufficiency present. The principal defect in this syndrome is a reduced level of plasma renin activity, which results in secondary hypoaldosteronism. Diabetes mellitus is usually the primary underlying renal disease, though other causes of renal diseases associated with this syndrome have been described. This case report describes for the first time an elderly patient with
multiple myeloma
, in remission for more than 11 years, associated with the syndrome of
hyporeninemic hypoaldosteronism
at the time of diagnosis. The complete resolution of the syndrome after vigorous chemotherapy is an intriguing possibility.
...
PMID:Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up. 822 76